Wednesday, June 8, 2016
Canadian Cancer Trials Group earned the unprecedented distinction of having two trials presented at the Plenary Session of the ASCO annual meeting on June 5th 2016.
Two cancer trials conducted by the Queen’s University-based Canadian Cancer Trials Group (CCTG) and lead scientific investigators Chris O’Callaghan and Wendy Parulekar have been recognized as among the highest impact studies in the world. Please see the links below to find out more about these important trials.
- 98.3 FlyFM - Queen's Cancer Trials Group Earns Top Spot
- No miracle cure for cancer suffered by Gord Downie, but research offers hope.
- Cancer trials recognized as best in the world
- Queen's News Release
- Asco News Release - Extended AI Therapy Improves DFS in Postmenopausal HR–Positive Breast Cancer
- Asco News Release - Temozolomide Improves Survival Over Radiation Alone in Elderly Patients With Glioblastoma
- CanIndia News: Canadian Cancer Society-funded glioblastoma trial reduces risk of death by 33 per cent
- Oncology Nurse Advisor: Adding Temozolomide to radiotherapy improves survival in elderly patients with newly diagnosed Glioblastoma
- Age Not an Issue: Chemo Also for Elderly Glioblastoma